Authorities in Fangchenggang City, Guangxi Zhuang Autonomous Region, have recently identified and cleared 148 dormant medical device companies from the market. The local Market Supervision and Administration Bureau conducted a comprehensive investigation by leveraging county and township-level regulatory networks, integrating daily supervision records, and verifying information through on-site visits and business location checks.

The initiative aimed to ascertain the actual operational status of medical device enterprises within the jurisdiction. Building on an initial database of 923 registered medical device distributors, the bureau organized grassroots regulatory teams to conduct a new round of thorough, blanket inspections. Each company was individually verified for details such as business address, staff presence, storage facilities, and business transactions, enabling precise identification of entities that had ceased operations long-term or were not conducting actual business.

To date, 148 companies have been identified as long-term inactive, non-operational, or unreachable, laying a solid foundation for subsequent cleanup and rectification efforts.

The bureau conducted centralized analysis and precise categorization of the collected enterprise information, clarifying disposal directions and refining measures to achieve full-process control from "identification—analysis—disposal—closure." On one front, policy guidance was strengthened. Companies were proactively informed of their rights and obligations, and those with no ongoing operations or business needs were encouraged to voluntarily apply for deregistration through the digital government service platform, facilitating orderly market exit. Since the beginning of this year, 25 companies have applied for deregistration.

On another front, regulatory deterrence was enhanced. Companies that were long-term inactive, unreachable, and had not applied for deregistration were compiled into a list of abnormal enterprises and publicly disclosed in accordance with the law. So far, 110 companies have been publicly listed. Following the disclosure period, these entities will be batch-removed from the Guangxi Digital Government Service Platform system, enabling dynamic cleanup and promoting the healthy development of the medical device distribution market.